|
Match
|
Document |
Document Title |
|
|
US20090285891 |
Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production
Any pharmaceutical preparation for oral administration with controlled release of active ingredient in the small bowel, on the basis of active ingredient carriers provided with at least one active...
|
|
|
US20090285886 |
ENHANCED ANTIMICROBIAL ACTIVITY OF PLANT ESSENTIAL OILS
Antimicrobial compositions based on a combination of plant essential oils of enhanced antimicrobial effectiveness are prepared by adding to the combination of at least two plant essential oils, a...
|
|
|
US20090285865 |
Palatable, solid oral formulations for male chemical sterilization
Palatable, solid oral formulations or compositions include at least one bioactive agent capable of chemical sterilization of human and animal males. Depending on the targeted species, the bioactive...
|
|
|
US20090285864 |
THERAPEUTIC FORMULATION
The invention provides compositions and formulations comprising catechol and/or acetogenins and various combinations thereof; including various combinations with other ingredients including...
|
|
|
US20090285863 |
Coating Composition Comprising Starch
The present invention provides a coating composition comprising an aqueous medium and, dispersed therein, starch and a film-forming agent which controls swelling of the starch by the aqueous...
|
|
|
US20090285862 |
METHODS AND COMPOSITION FOR TREATMENT OF INFLAMMATORY PAIN
The present invention relates to the field of pain management, and in particular, the management of inflammatory pain without inducing overt sedation. The present invention features compositions...
|
|
|
US20090280176 |
CONTROLLED RELEASE FORMULATIONS OF ALPRAZOLAM
A controlled release formulation of alprazolam for once a day administration to a mammalian subject, which formulation releases alprazolam along a pre-determined release profile, is provided.
|
|
|
US20090280160 |
PHENYLEPHRINE PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION
Pharmaceutical compositions comprising phenylephrine or a pharmaceutically acceptable salt thereof and methods for administering the pharmaceutical compositions wherein the composition is...
|
|
|
US20090274757 |
PHARMACEUTICAL POLISH FORMULATIONS
Polish compositions for coating pharmaceutical solid dosage forms such as tablets are disclosed. The polish composition comprises water, coating agent, and a film forming agent. Polished...
|
|
|
US20090274756 |
Stabilized composition
It is intended to provide a pharmaceutical composition which contains a proton pump inhibitor and is stable even if it is stored for a long time. It is also intended to provide a pharmaceutical...
|
|
|
US20090274755 |
Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
The present invention is directed to a process for the catalytic oxidation of the thioether 5-methoxy-2-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)meth
ylthio)-1H-benzimidazole to its sulfoxide:...
|
|
|
US20090274740 |
DRUG-LOADED MEDICAL DEVICES AND METHODS FOR MANUFACTURING DRUG-LOADED MEDICAL DEVICES
Drug-loaded medical devices such as stents and methods for manufacturing them are provided. In certain embodiments, the therapeutic agent is loaded only in or on areas of the medical device that do...
|
|
|
US20090274733 |
Pharmaceutical preparation containing copolyvidone
A stabilized preparation which comprises: a unstable drug in a polyethylene glycol-containing preparation; and a coating agent comprising a copolyvidone instead of polyethylene glycol with which...
|
|
|
US20090274732 |
Type-2 Diabetes Combination Wafer
Rapidly disintegrating oral dosage forms for the application of active agent combinations for diabetes therapy. The dosage forms contain at least two active agents suitable for treating type-2...
|
|
|
US20090274731 |
PRODUCTION OF ENVELOPED PHARMACEUTICAL DOSAGE FORMS
A process for at least partially enveloping a pharmaceutical dosage form, in which the dosage form is surrounded by a shrinkable film, and the film is subsequently shrunk is described.
|
|
|
US20090274730 |
COMPOSITIONS AND METHODS FOR TREATING INFLAMMATION
Provided are electrokinetically-generated fluids (e.g., gas-enriched electrokinetic fluids or solutions), and therapeutic compositions and methods for use in treating inflammation or at least one...
|
|
|
US20090269397 |
TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS
Polymeric delivery devices have been developed which combine high loading/high density of molecules to be delivered with the option of targeting. As used herein, “high density” refers to...
|
|
|
US20090269395 |
USE OF PROTOBERBERINES AS AN ACTIVE SUBSTANCE REGULATING THE PILOSEBACEOUS UNIT
The present invention relates to cosmetic use, by topic application on the skin of at least one protoberberine, with exception of berberine, or a vegetable extract containing it, as an active...
|
|
|
US20090269394 |
METHODS AND COMPOSITIONS FOR TREATING ONCHOMYCOSIS
The present invention relates to methods for treating and completely curing fungal, yeast and/or mold infections in human subjects comprising topically administering to a human subject in need...
|
|
|
US20090269388 |
ALLOGRAFT BONE COMPOSITION HAVING A GELATIN BINDER
The invention is directed toward an osteoimplant for application to a bone defect site to promote new bone growth at the site which comprises a new bone growth inducing composition of demineralized...
|
|
|
US20090269373 |
Saposin C-DOPS: A Novel Anti-Tumor Agent
Compositions and methods for treating subjects with disorders characterized by hyper-proliferating cells such as tumors and cancers are provided. The compositions comprise agents that are...
|
|
|
US20090263482 |
Treatment of inflammatory bowel disease with 6-mercaptopurine
Methods of administering a delayed release 6-mercaptopurine pharmaceutical composition to patients suffering from inflammatory bowel disease which provide for release of the 6-mercaptopurine after...
|
|
|
US20090263477 |
SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF
In one aspect, the present invention relates to a formulation in the form of molecular dispersion comprising i) fenofibric acid, a physiologically acceptable salt or derivative thereof and...
|
|
|
US20090263432 |
STABLE COMBINATIONS OF AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE
The present invention provides a pharmaceutical composition comprising benazepril and amlodipine wherein the benazepril and the amlodipine are in physical contact with one another, and methods for...
|
|
|
US20090263431 |
POLYURETHANE FOAMS FOR WOUND MANAGEMENT
The invention relates to a process for producing polyurethane foams for wound management wherein a composition containing a polyurethane dispersion and specific coagulants is frothed and dried.
|
|
|
US20090263430 |
Multilayer Silk Protein Films
The present invention is directed to a method of forming multilayer silk protein films and a multilayer film obtained therefrom. The invention is further directed to various materials, products and...
|
|
|
US20090263429 |
Method of Preparing a Hydrogel
A method of preparing a hydrogel comprises: (i) reacting a first molecule comprising a carboxylic acid group and second molecule comprising an amine group or an alcohol group with a hydrolase...
|
|
|
US20090258079 |
Biocompatible Block Copolymer, Use Thereof and Manufacturing Method Thereof
A biocompatible block copolymer having a hydrophobic segment composed of amino acid and hydroxycarboxylic acid and a hydrophilic segment composed of polyalkylene oxide, wherein the terminal not...
|
|
|
US20090258040 |
STEROID TREATMENT FOR HOT FLASHES
Embodiments of the invention relate to methods for treating individuals suffering from hot flashes by vomeronasally administering a therapeutically effective dosage of a steroid agent. The hot...
|
|
|
US20090258039 |
Method of administering a pharmaceutical active ingredient
A method for reducing the friability of soft substrates by applying an effective amount of a water soluble, polymeric dispersion to at least a portion of a treatment surface of the substrate, such...
|
|
|
US20090258038 |
WATER-SOLUBLE COMPOSITIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS
Water-soluble compositions comprising a lipophilic compound and a solubilizing agent of the general formula:
{X—OOC—[(CH 2 ) n...
|
|
|
US20090252778 |
METHODS AND DEVICES FOR REDUCING TISSUE DAMAGE AFTER ISCHEMIC INJURY
Methods and devices are provided for the delivery of therapeutic agents which reduce myocardial tissue damage due to ischemia and anti-restenotic agents which inhibit restenosis following a cardiac...
|
|
|
US20090252770 |
NON-DIGESTIBLE SUGAR-COATED PRODUCTS AND PROCESS
A method and composition are provided for coating a component to achieve colon-targeted delivery. A component is coated with a fructose-based non-digestible carbohydrate such as a inulin,...
|
|
|
US20090252769 |
PREVENTIVE AND THERAPEUTIC VACCINE FOR STORKE AND NEUROLOGICAL DISORDERS
A method for producing therapeutic vaccine which consist of NMDA-NR1 subunit expressed in insect cells to produce recombinant protein and was encapsulated in poly(D-L-lactide-co-glycolic-acid)...
|
|
|
US20090252768 |
USE OF STILBENE DERIVATIVES FOR TREATMENT AND PREVENTION OF AQUATIC MOLD INFECTIONS
The invention relates to methods of treatment and prevention of aquatic mold infections in aquatic organisms and methods of disinfecting equipment used in raising aquatic organisms. The methods...
|
|
|
US20090252767 |
Water dispersible enteric coating formulation of nutraceutical and pharmaceutical dosage forms
The present invention relates to formulations for use as enteric coatings. More particularly, the present invention relates to a formulation comprising a dry blend of food grade ingredients that...
|
|
|
US20090246288 |
Taste-masking oral dosage form and method of preparing the same
The present invention provides a taste-masking oral dosage form which comprises a taste-masked microparticle and an excipient. The taste-masked microparticle comprises a taste-masked crystal...
|
|
|
US20090246276 |
Pharmaceutical Compositions
The present invention relates to a pharmaceutical composition comprising a tablet core comprising a combination of actives selected from the group consisting of bupropion hydrochloride and...
|
|
|
US20090246233 |
Treatment of Gastroparesis and Nonulcer Dyspepsia With GABAB Agonists
The present invention relates to formulations comprising a therapeutically effective amount of baclofen or (R)-baclofen, or pharmaceutically acceptable salts thereof, and methods of their use. The...
|
|
|
US20090246232 |
Pharmaceutical composition
Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent...
|
|
|
US20090246231 |
Formulations containing borojo
The present invention relates to a cosmetic and skin care formulation comprising: borojo; and at least one humectant; and at least one emollient. The present invention also provides for a dietary...
|
|
|
US20090246127 |
TARGETING AGENTS FOR MOLECULAR IMAGING
This invention discloses a method of synthesizing targeting contrast agents for molecular imaging and targeting diagnosis and therapy, targeting contrast agents and targeting therapeutic agents and...
|
|
|
US20090238879 |
DELIVERY SCAFFOLDS AND RELATED METHODS OF USE
The present invention relates to delivery systems. In particular, the present invention provides microporous scaffolds having thereon agents (e.g., extracellular matrix proteins, exendin-4) and...
|
|
|
US20090238869 |
PROPRANOLOL FORMULATIONS
Controlled-release propranolol formulations comprise a core comprising a pharmaceutically acceptable propranolol salt and an inert core; and a coating disposed on the core, the coating comprising...
|
|
|
US20090238847 |
Deodorant Particle
Disclosed is a deodorant particle having a BET specific surface area of 10 m 2 /g or more that are obtained by copolymerizing a monomer system including a crosslinkable vinyl monomer and a vinyl...
|
|
|
US20090238846 |
S/O type external preparation
The present invention provides an external preparation which can improve a skin permeability of a hydrophilic medicine such as NSAID so that the medicine can act directly on a diseased area without...
|
|
|
US20090232856 |
STABLE THREE-PHASED EMULSIONS
Disclosed is a three-phase emulsion comprising an aqueous-gel outer phase; and a water-in-oil inner phase, wherein the emulsion is stable. The aqueous-gel outer phase can include 10% to 50% by...
|
|
|
US20090232854 |
USES OF BISPECIFIC ANTIBODY COATED DENDRITIC CELLS PULSED WITH ANTIGENS AND GM-CSF IN IMMUNE REGULATION
GM-CSF administered before immunization exerted a sustained suppressive effect against the induction of myasthenia gravis (MG). This suppression was associated with lowered serum autoantibody...
|
|
|
US20090232853 |
TREATMENT OF LAMINITIS
The present invention provides a composition comprising one or more of a matrix metalloprotease inhibitor, a de-carboxylase inhibitor, a fructanase enzyme and/or a flavonoid for use in the...
|
|
|
US20090226491 |
Water-based delivery systems
The invention relates to a water-based delivery system for an active substance, characterized by enhancing skin barrier restoration in the stratum corneum comprising water, a fatty acid,...
|